OpenAlex
PricingAboutJobs
Log inGet started
Work

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

HTML

Year: 2005
Type: article
Study design: Clinical Trial
Source: Breast Cancer Research and Treatment
DOI: 10.1007/s10549-004-1720-2
Authors: Gunter von Minckwitz, Walter Jonat, Peter Fasching, Andreas du Bois, Ulrich Kleeberg, Hans-Joachim Lück, Erika Kettner, Jörn Hilfrich, Wolfgang Eiermann, Julie Torode, Andreas Schneeweiss
Institutions: Goethe University Frankfurt, German Breast Group, University Hospital Frankfurt, University Hospital Schleswig-Holstein, Universitätsklinikum Erlangen, Helios Dr. Horst Schmidt Kliniken Wiesbaden, Medizinische Hochschule Hannover, Klinikum Magdeburg, Rotkreuzklinikum München, AstraZeneca (Germany), University Hospital Heidelberg, Frauenklinik Heidelberg
Language: English

Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: gefitinib, metastatic breast cancer, EGFR tyrosine kinase inhibitors, anthracycline pretreated, EGFR expression, treatment response, adverse events, survival, drug tolerability
SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca
OpenAlex ID: W2012300394
FWCI: 10.19
Cites: 24
Cited by: 186
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms